↓ Skip to main content

Dove Medical Press

Article Metrics

Current and emerging drugs for the treatment of inflammatory bowel disease

Overview of attention for article published in Drug Design, Development and Therapy, April 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 1,830)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
46 news outlets
twitter
1 tweeter
patent
11 patents

Citations

dimensions_citation
172 Dimensions

Readers on

mendeley
317 Mendeley
Title
Current and emerging drugs for the treatment of inflammatory bowel disease
Published in
Drug Design, Development and Therapy, April 2011
DOI 10.2147/dddt.s11290
Pubmed ID
Authors

John Triantafillidis

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 317 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Uganda 1 <1%
South Africa 1 <1%
Czechia 1 <1%
Singapore 1 <1%
United States 1 <1%
Philippines 1 <1%
Unknown 311 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 55 17%
Student > Ph. D. Student 48 15%
Student > Bachelor 44 14%
Researcher 41 13%
Other 27 9%
Other 58 18%
Unknown 44 14%
Readers by discipline Count As %
Medicine and Dentistry 73 23%
Agricultural and Biological Sciences 58 18%
Biochemistry, Genetics and Molecular Biology 31 10%
Pharmacology, Toxicology and Pharmaceutical Science 20 6%
Chemistry 14 4%
Other 52 16%
Unknown 69 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 365. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2021.
All research outputs
#52,189
of 18,908,606 outputs
Outputs from Drug Design, Development and Therapy
#5
of 1,830 outputs
Outputs of similar age
#827
of 258,638 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 124 outputs
Altmetric has tracked 18,908,606 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,830 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.